Daiichi Sankyo Nordics ApS: Financial statements 2026
CVR: 39371049
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Daiichi Sankyo Nordics ApS (CVR 39371049) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. That is an increase of 20.3% compared with the year before. Equity in the 2026 report amounted to DKK 40,346,412. The solvency ratio was 12.9%. The company had 41 employees in the financial year.
- Gross Profit
- DKK 83,558,930
- Profit/Loss
- DKK 17,269,490
- Equity
- DKK 40,346,412
- Total Assets
- DKK 313,233,740
- Employees
- 41
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 83.6M | 17.3M | 40.3M | 41 |
| 2025 | - | 69.5M | 9M | 23.1M | 38 |
| 2024 | - | 57.4M | 8.4M | 14.1M | 26 |
| 2023 | - | 47.8M | 2.4M | 5.7M | 24 |
| 2022 | - | 35.6M | 46K | 3.4M | 22 |
Official annual report
Find more companies like Daiichi Sankyo Nordics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Daiichi Sankyo Nordics ApS has won the tender "Amgros 2026 1.152.a" issued by Amgros I/S worth 167,000,000 DKK.
Contact info changed: new phone: 27219263, new email: [email protected] (February 2, 2026).
As of February 1, 2026, Christophe Tiberghien has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Åke Magnus Gisel has left the board of directors of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Christophe Tiberghien is registered as director of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Åke Magnus Gisel has stepped down as director of Daiichi Sankyo Nordics ApS.
About Daiichi Sankyo Nordics ApS
Daiichi Sankyo Nordics ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Daiichi Sankyo Oncology Nordics ApS. The management consists of Christophe Tiberghien. The board consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg. The company is owned by Daiichi Sankyo Oncology Europe GmbH. The company has 32 employees (2026). In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. Equity in the 2026 report amounted to DKK 40,346,412.
